APA (7th ed.) Citation

R, M., M, B., P, R., W, C., MV, M., J, L., . . . PM, V. (2026). Talquetamab-Daratumumab in Relapsed or Refractory Myeloma. The New England journal of medicine. https://doi.org/10.1056/NEJMoa2604657

Chicago Style (17th ed.) Citation

R, Mina, et al. "Talquetamab-Daratumumab in Relapsed or Refractory Myeloma." The New England Journal of Medicine 2026. https://doi.org/10.1056/NEJMoa2604657.

MLA (9th ed.) Citation

R, Mina, et al. "Talquetamab-Daratumumab in Relapsed or Refractory Myeloma." The New England Journal of Medicine, 2026, https://doi.org/10.1056/NEJMoa2604657.